<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05076318</url>
  </required_header>
  <id_info>
    <org_study_id>Dysregulated urea-synthesis</org_study_id>
    <nct_id>NCT05076318</nct_id>
  </id_info>
  <brief_title>Dysregulated Urea-synthesis at Terminal Uremia</brief_title>
  <official_title>Dysregulated Urea-synthesis at Terminal Uremia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project will examine the dysregulation of the urea cycle in patients with terminal&#xD;
      uremia using a validated method named &quot;Functional Hepatic Nitrogen Clearance&quot;&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Urea synthesis rate during alanine infusion</measure>
    <time_frame>4 hours. 1 hour of blood sample measuring of baseline urea-synthesis rate and 3 hours of urea-synthesis rate during alanine-infusion</time_frame>
    <description>Change in the synthesis of urea during a 3 hour period of alanine-infusion in pre and post hemodialysis patients. We will use a validated method named functional hepatic nitrogen clearance (FHNC) to evaluate the synthesis of urea. FHNC is calculated using the linear relation between urea nitrogen synthesis rate and blood-amino acid which is measured every hour. An estimated group of 10 dialysis patients will be included and compared to a clinical healthy group. The healthy group has also received alanine infusion and blood samples of urea and amino-acids has likewise been measured for every hour of infusion.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Urea Cycle Disorder</condition>
  <condition>Uremia</condition>
  <arm_group>
    <arm_group_label>Alanine-infusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Alanine infusion taking place over a 3 hour period while monitorering metabolic changes in blood samples before and after dialysis</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Aminoacid, alanine-infusion</intervention_name>
    <description>During 3 hours, patient will receive alanine-infusion, while amino-acid and urea will be monitored by blood samples.</description>
    <arm_group_label>Alanine-infusion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt; or equal to 18 years&#xD;
&#xD;
          -  Chronic hemodialysis during 3 months&#xD;
&#xD;
          -  Patients with functioning arteriovenous-fistula assigned to &quot;Center-Hemodialysis&quot; at&#xD;
             &quot;Nyresygdomme, AUH Skejby&quot;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Active infection&#xD;
&#xD;
          -  Conditions with vomiting or diarrhea&#xD;
&#xD;
          -  Diabetes&#xD;
&#xD;
          -  Active disease being treated with chemotherapy, radiationtherapy, biologic- or similar&#xD;
             treatments. Disease under observation can be included.&#xD;
&#xD;
          -  Liver disease&#xD;
&#xD;
          -  Vessels on the upper extremities not suited for cannulation&#xD;
&#xD;
          -  Prednisolone treatment during the last 8 weeks&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  BMI &gt; or equal to 30 or &lt; or equal to 18&#xD;
&#xD;
          -  Physically or mentally condition that does not allow the project to be completed&#xD;
&#xD;
          -  Language-difficulties that does not allow the project to be completed&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rasmus Eriksen, MD</last_name>
    <phone>30264691</phone>
    <email>rasmus.s.eriksen@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Aarhus</name>
      <address>
        <city>Aarhus N</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rasmus Eriksen, MD</last_name>
      <phone>30264691</phone>
      <email>raerik@rm.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>August 26, 2021</study_first_submitted>
  <study_first_submitted_qc>October 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 13, 2021</study_first_posted>
  <last_update_submitted>October 12, 2021</last_update_submitted>
  <last_update_submitted_qc>October 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urea Cycle Disorders, Inborn</mesh_term>
    <mesh_term>Uremia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

